KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Shares Outstanding (2016 - 2025)

LifeMD's Shares Outstanding history spans 14 years, with the latest figure at $46.8 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 10.56% year-over-year to $46.8 million; the TTM value through Dec 2025 reached $46.8 million, up 10.56%, while the annual FY2025 figure was $46.8 million, 10.56% up from the prior year.
  • Shares Outstanding reached $46.8 million in Q4 2025 per LFMD's latest filing, roughly flat from $46.7 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $46.8 million in Q4 2025 to a low of $500000.0 in Q3 2021.
  • Average Shares Outstanding over 5 years is $17.5 million, with a median of $1.4 million recorded in 2021.
  • Peak YoY movement for Shares Outstanding: surged 2920.99% in 2024, then plummeted 96.65% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $30.7 million in 2021, then increased by 2.76% to $31.6 million in 2022, then crashed by 95.56% to $1.4 million in 2023, then soared by 2920.99% to $42.3 million in 2024, then grew by 10.56% to $46.8 million in 2025.
  • Per Business Quant, the three most recent readings for LFMD's Shares Outstanding are $46.8 million (Q4 2025), $1.4 million (Q3 2025), and $1.4 million (Q2 2025).